A variety of alkaline ceramidases (ACER1-3) were associated with Farber’s disease and involved in the regulation of cell viability in the small intestine and colon cancer (Coant et al., 2017), yet these activities were not recorded in treatment with cedrol. The gene discussed is ACER1; the disease is Farber lipogranulomatosis.